Bachem AG

Bachem is a global leader in the development and manufacture of peptides and oligonucleotides, driven by innovation and a commitment to quality. With over 50 years of experience, Bachem provides pharmaceutical and biotechnology companies worldwide with high-quality products for research, clinical development, and commercial applications, supported by a comprehensive range of specialist services.

Headquartered in Switzerland, Bachem has subsidiaries in the UK, USA, and Asia, ensuring a global reach with unmatched expertise in peptides. The company specializes in process development and the manufacture of peptides and complex organic molecules as APIs. Through internal research projects and collaborations, Bachem continuously expands its knowledge of chemistries and technologies, ensuring outstanding product quality and high yields.

Bachem prioritizes continuous investment in R&D, focusing on complex peptides and synthetic proteins, which present significant opportunities. Synthetic access to these macromolecules allows for substantial fine-tuning, enabling the development of patented products with tailored properties and optimized structures.

With five production sites in the US and Europe, Bachem offers research-level production and full cGMP manufacturing facilities on both continents. These facilities provide the capacity to produce APIs, key intermediates, small molecule generics, and new chemical entities (NCEs) at preclinical, clinical, and production scales.

Key Services:

• CMC Development
  • Development, GMP production, and regulatory support of peptide and oligonucleotide active pharmaceutical ingredients (API)
• Commercial APIs
  • Production of synthetic peptide and oligonucleotide APIs for exclusive NCEs and generic APIs at commercial scale

• Research & Specialties
  • Catalog peptides: Biologically active peptides for research purposes
  • Custom peptide synthesis: Support to bring your project from research scale to bulk GMP APIs
  • Diagnostics: Production of peptides for IVD at our ISO13485 certified site in St. Helens
  • Cosmetics: Supply of cosmetic peptides
  • Amino acid derivatives: Synthesis and supply of starting materials for peptide manufacturing

Founded in 1971 by Dr. Peter Grogg in Liestal near Basel, Bachem began with a focus on peptide synthesis. In 1978, the company moved to Bubendorf, ready to manufacture its first medicinal peptides. By its 50th anniversary in 2021, Bachem Group had grown into a global company employing more than 1,500 people across six locations worldwide.